|
PSMD14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.396000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.068200E-01 |
| Normal-vs-Stage2 |
9.956400E-01 |
| Normal-vs-Stage3 |
2.410200E-01 |
| Normal-vs-Stage4 |
5.835800E-02 |
| Stage1-vs-Stage2 |
8.093200E-01 |
| Stage1-vs-Stage3 |
2.555800E-01 |
| Stage1-vs-Stage4 |
7.981800E-02 |
| Stage2-vs-Stage3 |
3.852200E-01 |
| Stage2-vs-Stage4 |
1.558160E-01 |
| Stage3-vs-Stage4 |
3.961000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.690000E-01 |
| Normal-vs-AfricanAmerican |
4.954600E-01 |
| Normal-vs-Asian |
9.279600E-01 |
| Caucasian-vs-AfricanAmerican |
1.828980E-01 |
| Caucasian-vs-Asian |
4.657600E-01 |
| AfricanAmerican-vs-Asian |
5.074600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.877420E-01 |
| Normal-vs-Female |
6.763000E-01 |
| Male-vs-Female |
1.530950E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.594800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.135400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.091000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.503800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.582200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.157600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.601800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.839400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.451600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.810800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.549800E-01 |
| Classical-VS-Follicular |
3.795400E-01 |
| Classical-VS-Other |
3.380000E-01 |
| Classical-VS-Normal |
8.205600E-01 |
| Tall-VS-Follicular |
8.061800E-01 |
| Tall-VS-Other |
4.887600E-01 |
| Tall-VS-Normal |
5.647200E-01 |
| Follicular-VS-Other |
6.801600E-01 |
| Follicular-VS-Normal |
3.650800E-01 |
| Other-VS-Normal |
2.588200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.627400E-01 |
| Normal-vs-N1 |
5.709800E-02 |
| N0-vs-N1 |
2.642800E-01 |
|
|
